As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...
The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in ...
Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, ...
The prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, ...
Research has revealed that in the case of metabolic dysfunction-associated fatty liver disease (MAFLD), the risk of ...
Dr. Ben Galyardt told Newsweek: "There is no drug that will treat fatty liver. There is no surgery that will fix it." ...
A surge of stress-related drinking and alcohol-related deaths brought on by the Covid-19 pandemic in the US has not tapered ...
People with chronic liver disease have dramatic changes to the types and functions of bacteria in the gut and mouth, a new study has revealed.
Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...
PSRI Hospital is making strides in addressing complex liver conditions, especially those related to fatty liver disease and ...